Short Bowel Syndrome Drugs Market Size And Share

Report Code : TIPRE00021601
Category : Life Sciences

No. of Pages : 150

Buy Now

Principales conclusions et analyse des parts de marché des médicaments contre le syndrome de l'intestin court d'ici 2025-2031

Buy Now

Short Bowel Syndrome Drugs Market Report Analysis

Short Bowel Syndrome Drugs Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Takeda Pharmaceutical Company Limited
Pfizer Inc.
Novartis AG
Mylan N.V.
AstraZeneca Plc
Sancilio Pharmaceuticals Company, Inc.
Nutrinia Ltd
Ardelyx, Inc.
Merck and Co., Inc

Regional Overview

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et centrale
Moyen-Orient et Afrique

Market Segmentation

By Classe de médicaments

peptide de type glucagon
antidiarrhéiques
inhibiteurs de la pompe à protons
bloqueurs de l'histamine
hormone de croissance
autres

By Canal de distribution

hôpitaux et pharmacies de détail
distribution en ligne

By Géographie

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et Centrale